Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer


Cokmert S., Demir L. , Can A., Akyol M., Bayoglu I. V. , Dirican A., ...Daha Fazla

JOURNAL OF BUON, cilt.19, sa.1, ss.75-82, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Konu: 1
  • Basım Tarihi: 2014
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.75-82

Özet

Purpose: Erythrocyte mean corpuscular volume (MCV) increase has been described in patients treated with capaecitabine. In this study, we sought to evaluate the potential association of the erythrocyte MCV increase with tumor response and survival in patients with metastatic colorectal cancer (mCRC) treated with capecitabine.